Literature DB >> 32768270

Dupilumab-resistant facial erythema - Dermoscopic, histological and clinical findings of three patients.

Mari Nakanishi1, Risa Tamagawa-Mineoka2, Yukiyasu Arakawa1, Koji Masuda1, Norito Katoh1.   

Abstract

Entities:  

Year:  2020        PMID： 32768270     DOI： 10.1016/j.alit.2020.07.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  2 in total

1.  One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis.

Authors:  Hanjae Lee; Bo Ri Kim; Kyu Han Kim; Dong Hun Lee; Jung Im Na
Journal:  Allergy Asthma Immunol Res       Date:  2022-01       Impact factor: 5.764

Review 2.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.